PL362358A1 - Kompozycja farmaceutyczna zawierająca citalopram - Google Patents

Kompozycja farmaceutyczna zawierająca citalopram

Info

Publication number
PL362358A1
PL362358A1 PL02362358A PL36235802A PL362358A1 PL 362358 A1 PL362358 A1 PL 362358A1 PL 02362358 A PL02362358 A PL 02362358A PL 36235802 A PL36235802 A PL 36235802A PL 362358 A1 PL362358 A1 PL 362358A1
Authority
PL
Poland
Prior art keywords
pharmaceutical composition
composition containing
containing citalopram
citalopram
pharmaceutical
Prior art date
Application number
PL02362358A
Other languages
English (en)
Inventor
Ken Liljegren
Per Holm
Original Assignee
H.Lundbeck A/S
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by H.Lundbeck A/S filed Critical H.Lundbeck A/S
Publication of PL362358A1 publication Critical patent/PL362358A1/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/87—Benzo [c] furans; Hydrogenated benzo [c] furans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
    • A61K31/343—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide condensed with a carbocyclic ring, e.g. coumaran, bufuralol, befunolol, clobenfurol, amiodarone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1635—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1682—Processes
    • A61K9/1688—Processes resulting in pure drug agglomerate optionally containing up to 5% of excipient
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Pain & Pain Management (AREA)
  • Psychiatry (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
PL02362358A 2001-01-05 2002-01-03 Kompozycja farmaceutyczna zawierająca citalopram PL362358A1 (pl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DKPA200100016 2001-01-05
PCT/DK2002/000003 WO2002053133A1 (en) 2001-01-05 2002-01-03 Pharmaceutical composition containing citalopram

Publications (1)

Publication Number Publication Date
PL362358A1 true PL362358A1 (pl) 2004-10-18

Family

ID=8159961

Family Applications (1)

Application Number Title Priority Date Filing Date
PL02362358A PL362358A1 (pl) 2001-01-05 2002-01-03 Kompozycja farmaceutyczna zawierająca citalopram

Country Status (22)

Country Link
US (1) US20040058989A1 (pl)
EP (1) EP1351667A1 (pl)
JP (1) JP2004517111A (pl)
KR (1) KR20030070088A (pl)
CN (1) CN1484523A (pl)
AU (1) AU2001100195B4 (pl)
BG (1) BG108034A (pl)
BR (1) BR0206272A (pl)
CA (1) CA2358356A1 (pl)
CZ (1) CZ20032119A3 (pl)
EA (1) EA005596B1 (pl)
HR (1) HRP20030546A2 (pl)
HU (1) HUP0302531A3 (pl)
IL (1) IL156547A0 (pl)
IS (1) IS6857A (pl)
MX (1) MXPA03005965A (pl)
NO (1) NO20033073L (pl)
PL (1) PL362358A1 (pl)
SK (1) SK9912003A3 (pl)
WO (1) WO2002053133A1 (pl)
YU (1) YU54503A (pl)
ZA (1) ZA200304860B (pl)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2406592C (en) * 2002-10-04 2003-09-30 Duchesnay Inc. Method of preparing pharmaceutical dosage forms containing multiple active ingredients
WO2004082615A2 (en) * 2003-03-14 2004-09-30 Nirmal Mulye A process for preparing sustained release tablets
HU227491B1 (en) * 2003-11-25 2011-07-28 Egis Gyogyszergyar Nyilvanosan Muekoedoe Reszvenytarsasag Tablet containing citalopram hydrogen bromide
US20110196032A1 (en) * 2005-05-20 2011-08-11 Ashish Gogia Pharmaceutical Dosage Form of an Antidepressant
CN100353939C (zh) * 2006-01-05 2007-12-12 昆明积大制药有限公司 含西酞普兰和环糊精的抗抑郁口服药用组合物

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1358915A (en) * 1971-09-13 1974-07-03 Merck & Co Inc Directly compressed tablet and composition therefor
GB1526331A (en) * 1976-01-14 1978-09-27 Kefalas As Phthalanes
GB2357762B (en) * 2000-03-13 2002-01-30 Lundbeck & Co As H Crystalline base of citalopram
US6977306B2 (en) * 2000-05-02 2005-12-20 Sumitomo Chemical Company, Limited Citalopram hydrobromide crystal and method for crystallization thereof
CA2353693C (en) * 2000-08-10 2003-07-22 H. Lundbeck A/S Pharmaceutical composition containing citalopram

Also Published As

Publication number Publication date
AU2001100195B4 (en) 2001-12-20
SK9912003A3 (en) 2003-12-02
KR20030070088A (ko) 2003-08-27
MXPA03005965A (es) 2003-09-05
NO20033073D0 (no) 2003-07-04
AU2001100195A4 (en) 2001-08-16
BR0206272A (pt) 2003-12-30
CN1484523A (zh) 2004-03-24
CZ20032119A3 (en) 2004-03-17
HUP0302531A3 (en) 2007-06-28
NO20033073L (no) 2003-07-04
BG108034A (bg) 2005-02-28
US20040058989A1 (en) 2004-03-25
CA2358356A1 (en) 2002-01-20
JP2004517111A (ja) 2004-06-10
EP1351667A1 (en) 2003-10-15
ZA200304860B (en) 2004-06-30
EA005596B1 (ru) 2005-04-28
YU54503A (sh) 2006-05-25
HUP0302531A2 (hu) 2003-11-28
WO2002053133A1 (en) 2002-07-11
IL156547A0 (en) 2004-01-04
HRP20030546A2 (en) 2005-06-30
EA200300768A1 (ru) 2003-10-30
IS6857A (is) 2003-06-23

Similar Documents

Publication Publication Date Title
EP1450824A4 (en) PHARMACEUTICAL COMPOSITION
GB0111597D0 (en) Pharmaceutical compositions
HUP0303163A3 (en) Tramadol-based pharmaceutical composition
GB0117057D0 (en) Pharmaceutical composition
EP1398040A4 (en) MEDICAL COMPOSITION
GB0129117D0 (en) Pharmaceutical composition
GB2368014B (en) Pharmaceutical composition containing citalopram
GB0116107D0 (en) Pharmaceutical composition
GB0104752D0 (en) Pharmaceutical compositions
GB0127805D0 (en) Pharmaceutical composition
PL370037A1 (pl) Kompozycja farmaceutyczna
HRP20030546A2 (en) Pharmaceutical composition containing citalopram
GB0114746D0 (en) Medicinal composition
IL159614A0 (en) Benzofuran derivatives and pharmaceutical compositions containing the same
GB2382302B (en) Pharmaceutical compositions
IL157411A0 (en) Pharmaceutical composition
HU0103049D0 (en) Pharmaceutical composition
GB0125061D0 (en) Pharmaceutical composition
GB0126732D0 (en) Pharmaceutical compositions
GB0104751D0 (en) Pharmaceutical composition
GB0101584D0 (en) Pharmaceutical composition
GB0121546D0 (en) Pharmaceutical composition
GB0130957D0 (en) Pharmaceutical composition
GB0102462D0 (en) Pharmaceutical composition
AP2002002507A0 (en) Pharmaceutical composition

Legal Events

Date Code Title Description
REFS Decisions on refusal to grant patents (taken after the publication of the particulars of the applications)